Samumed's Option/Warrant Round

Samumed raised a round of funding on January 02, 2008. Investors include Pfizer.

Samumed, formerly known as Wintherix & Epitherix, has identified a number of novel drug compounds to selectively activate or inhibit the Wnt pathway toward regenerative medicine and treatment of oncol…

Articles about Samumed's Option/Warrant Round: